173404 A comparison of congenital anomalies on birth and death certificates

Tuesday, October 28, 2008

Louie Albert Woolbright, PhD , Center for Health Statistics, Alabama Department of Public Health, Montgomery, AL
Congenital anomalies have now become the leading cause of infant mortality in the United States. Birth defects also are a leading cause of developmental disabilities. As a result, there is a need for accurate and complete data on birth defects. One possible source of data is birth certificates. Birth certificates are available for all births in the United States and data can be obtained cheaply and efficietly. However, problems exit in using birth certificate data on congenital anomalies. Birth certificates and infant death certificates from Alabama from 1988-2005 were linked to see if birth certificates indicated an anomaly when the baby died of an anomaly. In almost two thirds of the cases where the baby died of an anomaly, there was no indication of an anomaly on the birth certificates. Reporting was universally poor and did not greatly vary by the characteristics of the mother or hospital. The conclusion is that birth certificates are a poor medium for collecting information on birth defects.

Learning Objectives:
1. Strengths and weakness of vital statistics data 2. How a comparison of different sources can help evaluate the quality of data 3. Reporting varies by characteristics of the mother and hospital

Keywords: Birth Defects, Infant Mortality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in the field of health statistics for more than 20 years. I have published articles in several public health journals including: Annals of Epidemiology, International Journal of Epidemiology, Public Health Reports, Southern Medical Journal, Popuklation Policy and Research Review, and Birth.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.